
Axonics Modulation Technologies Income Statement 2023-2011 | AXNX
Brief overview of financial performance at Axonics Modulation Technologies
The figures are compared over a five-year interval. Axonics Modulation Technologies reported revenue of 707 thousand dollars in 2018 and 366 million dollars by 2023. The total change was +51721.6%, with a CAGR of approximately 249.1%. Revenue growth reflects a pronounced phase of business expansion.
At the gross-profit level, the result moved from $351 thousand to $275 million, a change of +78120.5%. The relationship between sales and direct costs improved over the period. At the margin level, the figure shifted from 49.6% to 74.9%. The expansion indicates stronger pricing power or better control of direct costs.
The five-year EBITDA result moved by +56.5%: from −31.2 million dollars to −13.6 million dollars. Operating performance weakened relative to revenue. Comparing the endpoints gives EBITDA margins of −4411.7% and −3.7%. The business generated more EBITDA from each unit of revenue.
The net financial result changed from −$32.5 million to −$6.1 million. The loss reduction is constructive, but the recovery is incomplete.
Financial takeaway
Positive developments coexist with areas of weakness. The financial profile benefits from a stronger final result, higher operating efficiency and sales growth. Caution is warranted because of a narrow EBITDA buffer. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement Axonics Modulation Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | 2.82 B | 2.41 B | 1.85 B | 792 M | 106 M | - | - | - | - | - | - | - |
Shares |
49.1 M | 46.7 M | 43.1 M | 37 M | 28.6 M | 7 M | 2.56 M | - | - | - | - | - | - |
Historical Prices |
- | 60.5 | 56 | 49.9 | 27.7 | 15.1 | - | - | - | - | - | - | - |
Net Income |
-6.09 M | -59.7 M | -80.1 M | -54.9 M | -79.9 M | -32.5 M | -18.1 M | -17.4 M | - | - | - | - | - |
Revenue |
366 M | 274 M | 180 M | 112 M | 13.8 M | 707 K | 128 K | - | - | - | - | - | - |
Cost of Revenue |
91.8 M | 76 M | 64.6 M | 44.4 M | 6.49 M | 356 K | 118 K | - | - | - | - | - | - |
Gross Profit |
275 M | 198 M | 116 M | 67.1 M | 7.33 M | 351 K | 10 K | - | - | - | - | - | - |
Operating Income |
-26.1 M | -64.9 M | -71.8 M | -53.8 M | -80.6 M | -32.1 M | -18.2 M | - | - | - | - | - | - |
Interest Expense |
624 K | -2.43 M | -7.43 M | -1.87 M | -2.31 M | -1.34 M | -22 K | - | - | - | - | - | - |
EBITDA |
-13.6 M | -53.2 M | -62.7 M | -52 M | -79.4 M | -31.2 M | -17.4 M | -16.8 M | - | - | - | - | - |
Operating Expenses |
301 M | 263 M | 188 M | 121 M | 87.9 M | 32.5 M | 18.2 M | - | - | - | - | - | - |
General and Administrative Expenses |
45.8 M | 40.2 M | 30 M | 25.6 M | 19.1 M | 9.36 M | 4.82 M | 4.46 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Axonics Modulation Technologies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
51.1 M | 50 M | 50.9 M | 50.8 M | 49.2 M | 49.1 M | 48.6 M | 49.5 M | 47.2 M | 45.3 M | 45.1 M | 46.3 M | 44.8 M | 42.8 M | 39.6 M | 39.9 M | 38.8 M | 36.4 M | 33.6 M | 34.1 M | 28.1 M | 27.9 M | 27.8 M | 27.8 M | 2.83 M | 2.82 M | 2.8 M | 2.78 M | 2.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-21 K | 6.9 M | -19.1 M | - | 3.93 M | -7.34 M | -9.25 M | - | -16.3 M | -21.4 M | -22.7 M | - | -17.2 M | -25.1 M | -22.5 M | - | -9.17 M | -19.8 M | -14.6 M | - | -25 M | -19.1 M | -13.1 M | - | -7.57 M | -8.65 M | -6.6 M | - | -4.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
116 M | 115 M | 91.4 M | - | 93.1 M | 92.9 M | 70.6 M | - | 70.4 M | 69 M | 48.4 M | - | 46.9 M | 45.9 M | 34.4 M | - | 35.2 M | 15.2 M | 26.3 M | - | 1.31 M | 1.49 M | 1.08 M | - | 201 K | 12 K | - | - | 128 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
26.5 M | 25.4 M | 22.2 M | - | 24 M | 22.7 M | 18.2 M | - | 19.1 M | 18.8 M | 15.2 M | - | 15.7 M | 17.1 M | 14 M | - | 13.4 M | 8.46 M | 9.9 M | - | 632 K | 772 K | 548 K | - | 106 K | 5 K | - | - | 118 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
89.7 M | 89.1 M | 69.3 M | - | 69.1 M | 70.2 M | 52.5 M | - | 51.3 M | 50.2 M | 33.2 M | - | 31.2 M | 28.7 M | 20.4 M | - | 21.8 M | 6.75 M | 16.4 M | - | 677 K | 716 K | 529 K | - | 95 K | 7 K | - | - | 10 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-6.27 M | 3.68 M | -19.2 M | - | -687 K | -12.1 M | -14.4 M | - | -16.4 M | -21.4 M | -23.5 M | - | -16.5 M | -16 M | -21.6 M | - | -8.77 M | -19.4 M | -14.7 M | - | -25 M | -19.3 M | -13.6 M | - | -7.54 M | -8.62 M | -6.53 M | - | -4.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
8 K | -32 K | -59 K | - | -83 K | 174 K | 683 K | - | -1.9 M | -839 K | -289 K | - | -229 K | -5.85 M | -1.45 M | - | -434 K | -443 K | -552 K | - | -586 K | -629 K | -532 K | - | -196 K | -234 K | -149 K | - | -8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
3.03 M | 9.76 M | -16 M | - | 8.61 M | -6.03 M | -11.6 M | - | -7.53 M | -15.5 M | -20.5 M | - | -10 M | -12.2 M | -20.5 M | - | -7.52 M | -18.6 M | -14.3 M | - | -24.2 M | -18.7 M | -13.3 M | - | -6.88 M | -8.19 M | -6.31 M | - | -4.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
95.9 M | 85.5 M | 88.4 M | - | 69.8 M | 82.3 M | 66.9 M | - | 67.6 M | 71.6 M | 56.8 M | - | 47.7 M | 44.7 M | 42 M | - | 30.6 M | 26.2 M | 31.1 M | - | 25.7 M | 20 M | 14.1 M | - | 7.64 M | 8.62 M | 6.53 M | - | 4.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
23.8 M | 16.3 M | 15.1 M | - | 11.8 M | 10.7 M | 12.2 M | - | 9.39 M | 10.6 M | 10 M | - | 8.72 M | 8.04 M | 6.63 M | - | 5.77 M | 5.54 M | 7.65 M | - | 5.16 M | 4.36 M | 4.02 M | - | 2.79 M | 1.64 M | 1.44 M | - | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Axonics Modulation Technologies (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.